Legionnaire Disease Testing Market to Reach USD 819.5 Million by 2032 with 9% CAGR

The Legionnaire disease testing market is projected to experience significant growth, with an expected increase from USD 292 million in 2022 to approximately USD 819.5 million by 2032, reflecting a compound annual growth rate (CAGR) of 9% during the forecast period.

https://www.futuremarketinsigh....ts.com/reports/legio